Samyang Bio

Samyang Biopharmaceuticals Corp.'s pharmaceutical business is one of the three major growth drivers of the Samyang Group, along with the chemical and food businesses. Since its entry into the pharmaceutical business in 1995, Samyang Biopharmaceuticals Corp. has invested more than 20% of its annual sales in its pursuit of innovative R&D.
Number of products Number of products:
2

Where we are located

Our products

Filters

Reset current filters

Selected filters:

Type
Production region
Country of origin
Qualifications

Producer

Produced in:

South Korea

MOQ: -

  • CoA

  • CEP

  • USDMF

Contact supplier

Replies slower than most

Producer

Produced in:

South Korea

MOQ: -

  • CoA

  • CEP

  • USDMF

Contact supplier

Replies slower than most

Contact Samyang Bio and get a competitive price offer.

Samyang Bio is a supplier from South Korea. They offer 2 products (APIs, Excipients or Intermediates). Contact Samyang Bio for free and get a competitive price offer.

Find a price of Docetaxel bulk with CEP, USDMF offered by Samyang Bio.
Find a price of Paclitaxel bulk with CEP, USDMF offered by Samyang Bio.

Note that some products will only be visible after logging in.

Are you looking for pharmaceutical ingredients for the production of medicines? Contact the supplier of your choice by using the send inquiry button and find out how much it cost. The supplier will contact you with their price and conditions. Samyang Bio replies slower than most.

You can send an inquiry for these products. Some suppliers have set a minimum order quantity (moq). Provide enough information regarding your enquiry. Let Samyang Bio know whether you are looking for Ph.Eur (EP), USP, BP, JP grade. Also, let the manufacturer or trader know if you are looking for hydrochloride (HCl), base or other product specifications. Is it for own production, resale or research purposes? Contact Samyang Bio, get a price, download certificates and buy the product.

Samyang Bio


Samyang Biopharmaceuticals Corp.'s pharmaceutical business is one of the three major growth drivers of the Samyang Group, along with the chemical and food businesses. Since its entry into the pharmaceutical business in 1995, Samyang Biopharmaceuticals Corp. has invested more than 20% of its annual sales in its pursuit of innovative R&D.